New shot aims to tame dangerous liver virus
Disease control
Ongoing
This study is testing whether an experimental injection called Hepalatide (L47) can help control Hepatitis D, a serious liver infection. It will enroll 90 adults with stable liver function to receive either a low dose, a high dose, or delayed treatment for 48 weeks. The main goal…
Phase: PHASE2 • Sponsor: Shanghai HEP Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC